These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22923041)

  • 1. Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells.
    Li XY; Ding J; Zheng ZH; Li XY; Wu ZB; Zhu P
    Mol Med Rep; 2012 Nov; 6(5):1183-9. PubMed ID: 22923041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.
    Kronsteiner B; Wolbank S; Peterbauer A; Hackl C; Redl H; van Griensven M; Gabriel C
    Stem Cells Dev; 2011 Dec; 20(12):2115-26. PubMed ID: 21381973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
    Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
    Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Check-control of inflammation displayed by bone marrow mesenchymal stem cells in rheumatoid arthritis patients.
    Lamas JR; Mucientes A; Lajas C; Fernández-Gutiérrez B; Lópiz Y; Marco F; Jover JA; Abásolo L; Rodriguez-Rodriguez L
    Immunotherapy; 2019 Sep; 11(13):1107-1116. PubMed ID: 31378114
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulatory properties of colonic mesenchymal stem cells.
    Hu J; Zhang X; Zhou L; Zhang Y
    Immunol Lett; 2013; 156(1-2):23-9. PubMed ID: 24060593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of MSC on cell cycle, phenotype and cytokine secretion of T cells activated by PHA].
    Luan XY; Zhang GB; Hu YM; Yu GH; Wang MY; Duan QY; Duan X; Zhang XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):402-5. PubMed ID: 17488597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB.
    Dorronsoro A; Ferrin I; Salcedo JM; Jakobsson E; Fernández-Rueda J; Lang V; Sepulveda P; Fechter K; Pennington D; Trigueros C
    Eur J Immunol; 2014 Feb; 44(2):480-8. PubMed ID: 24307058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
    Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
    Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages.
    Kim J; Hematti P
    Exp Hematol; 2009 Dec; 37(12):1445-53. PubMed ID: 19772890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
    Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
    J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells.
    Kim DS; Ko YJ; Lee MW; Park HJ; Park YJ; Kim DI; Sung KW; Koo HH; Yoo KH
    Cell Stress Chaperones; 2016 Nov; 21(6):1089-1099. PubMed ID: 27565660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord-derived mesenchymal stem cells suppress proliferation of PHA-activated lymphocytes in vitro by inducing CD4(+)CD25(high)CD45RA(+) regulatory T cell production and modulating cytokine secretion.
    Yang H; Sun J; Li Y; Duan WM; Bi J; Qu T
    Cell Immunol; 2016 Apr; 302():26-31. PubMed ID: 26774852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation.
    Michelo CM; Fasse E; van Cranenbroek B; Linda K; van der Meer A; Abdelrazik H; Joosten I
    Transpl Immunol; 2016 Jul; 37():1-9. PubMed ID: 27142560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.
    Najar M; Raicevic G; Fayyad-Kazan H; De Bruyn C; Bron D; Toungouz M; Lagneaux L
    Stem Cell Rev Rep; 2015 Jun; 11(3):442-52. PubMed ID: 25326368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
    Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
    Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
    Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
    J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.